Heron Therapeutics Inc HRTX:NASDAQ

Last Price$3.05Cboe Real-Time Last Sale as of 11:23AM ET 7/06/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.05(1.67%)
Bid (Size)$3.05 (300)
Ask (Size)$3.06 (810)
Day Low / High$3.04 - 3.18
Volume548.1 K

View Biotechnology IndustryPeer Comparison as of 07/06/2022


Heron Therapeutics Inc ( NASDAQ )

Price: $3.05
Change: +0.05 (1.67%)
Volume: 548.1 K
11:23AM ET 7/06/2022

Scholar Rock Holding Corp ( NASDAQ )

Price: $7.00
Change: +1.12 (19.05%)
Volume: 839.5 K
11:26AM ET 7/06/2022

Lineage Cell Therapeutics Inc ( NYSE MKT LLC )

Price: $1.69
Change: 0.00 (0.00%)
Volume: 221.4 K
11:23AM ET 7/06/2022

Precigen Inc ( NASDAQ )

Price: $1.54
Change: -0.08 (4.94%)
Volume: 1.1 M
11:24AM ET 7/06/2022

Alpine Immune Sciences Inc ( NASDAQ )

Price: $8.98
Change: -0.01 (0.11%)
Volume: 18.6 K
11:21AM ET 7/06/2022

Read more news Recent News

Heron Therapeutics to Cut Workforce by 34% Under Restructuring Plan
9:25AM ET 6/30/2022 MT Newswires

Heron Therapeutics (HRTX) said Thursday that it has initiated a corporate restructuring and cost reduction plan that it expects will result in annualized...

--Cantor Fitzgerald Adjusts Price Target for Heron Therapeutics to $12 From $20, Maintains Overweight Rating
2:10PM ET 5/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Needham Adjusts Heron Therapeutics' Price Target to $14 from $16, Keeps Buy Rating
9:06AM ET 5/10/2022 MT Newswires

Heron Therapeutics (HRTX) has an average rating of buy and price targets ranging from $13 to $40, according to analysts polled by Capital IQ. (MT Newswires...

Heron Therapeutics Says Zynrelef Gets Pass-Through Payment Status From Centers for Medicare & Medicaid Services
9:34AM ET 3/25/2022 MT Newswires

Heron Therapeutics (HRTX) said Friday the Centers for Medicare and Medicaid Services has approved transitional pass-through status for its Zynrelef...

Company Profile

Business DescriptionHeron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA. View company web site for more details
Address4242 Campus Point Court
San Diego, California 92121
Number of Employees198
Recent SEC Filing06/30/20228-K
Chairman & Chief Executive OfficerBarry D. Quart
President & Chief Commercial OfficerJohn W. Poyhonen
Chief Operating Officer & Executive Vice PresidentDavid L. Szekeres
Chief Scientific Officer & SVP-PharmaceuticalThomas B. Ottoboni

Company Highlights

Price Open$3.02
Previous Close$3.00
52 Week Range$2.19 - 15.00
Market Capitalization$312.6 M
Shares Outstanding102.5 M
SectorHealth Technology
Next Earnings Announcement08/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.28
Beta vs. S&P 500N/A
Revenue$77.5 M
Net Profit Margin-258.35%
Return on Equity-243.86%

Analyst Ratings as of 07/30/2021

Consensus RecommendationConsensus Icon
Powered by Factset